Weekly News Recap #Phispers
EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3985
Apotex explores sale; Perrigo looks at selling prescription business; Takeda puts Latam biz on the block
This week, Phispers has good news for patients on sartan drugs.
For the first time since nitrosamine impurities were discovere...
Impressions : 7460
Astra strikes US$ 6.9 billion oncology deal with Daiichi; Cipla, Jubilant, Indoco’s FDA inspection updates
This week, Phispers brings you news about AstraZeneca’s US$ 6.9 billion deal with Japanese drug major Daiichi Sankyo, whe...
Impressions : 2723
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.